Amgen Balance Sheet Health
Financial Health criteria checks 1/6
Amgen has a total shareholder equity of $7.5B and total debt of $60.4B, which brings its debt-to-equity ratio to 802.4%. Its total assets and total liabilities are $90.9B and $83.4B respectively. Amgen's EBIT is $6.7B making its interest coverage ratio 2.1. It has cash and short-term investments of $9.0B.
Key information
802.4%
Debt to equity ratio
US$60.40b
Debt
| Interest coverage ratio | 2.1x |
| Cash | US$9.01b |
| Equity | US$7.53b |
| Total liabilities | US$83.36b |
| Total assets | US$90.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMGND's short term assets ($26.8B) exceed its short term liabilities ($20.3B).
Long Term Liabilities: AMGND's short term assets ($26.8B) do not cover its long term liabilities ($63.0B).
Debt to Equity History and Analysis
Debt Level: AMGND's net debt to equity ratio (682.7%) is considered high.
Reducing Debt: AMGND's debt to equity ratio has increased from 272.6% to 802.4% over the past 5 years.
Debt Coverage: AMGND's debt is not well covered by operating cash flow (12%).
Interest Coverage: AMGND's interest payments on its debt are not well covered by EBIT (2.1x coverage).